Log In
BCIQ
Print this Print this
 

Edratide (hCDR1) (formerly TV-4710)

  Manage Alerts
Collapse Summary General Information
Company Weizmann Institute of Science
DescriptionCDR1-based peptide derived from a human anti-DNA antibody
Molecular Target Cerebellar degeneration-related protein 1 (CDR1)
Mechanism of ActionImmune modulation
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation
PartnerXTL Biopharmaceuticals Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today